Abstract
Object
The relative amounts of choline (Cho), phosphocholine (PC), and glycerophosphocholine (GPC) may be sensitive indicators of breast cancer and the degree of malignancy. Here we implement some simple modifications to a previously developed 1H NMR analysis of fine-needle-aspirate (FNA) biopsies designed to yield sufficient spectral resolution of Cho, PC, and GPC for usable relative quantitation of these metabolites.
Materials and methods
FNA biopsies of eighteen breast lesions were examined using our modified procedure for direct 1H NMR at 400 MHz. Resonances of choline metabolites and potential interferences were fit using the computer program NUTS.
Results
Quantitation of PC, GPC, and Cho relative to each other and to (phospho)creatine was obtained for eleven confirmed cases of infiltrating ductal carcinoma. Reliable results could not be obtained for the remaining cases primarily due to interference from lidocaine anesthetic.
Conclusion
Some simple modifications of a previously developed 1H NMR analysis of FNAs yielded sufficient spectral resolution of Cho, PC, and GPC to permit usable relative quantitation at 400 MHz. In 9 of the 11 quantified cases the sum of GPC and Cho exceeded 42 % of the total choline-metabolite peak area.
Similar content being viewed by others
Abbreviations
- FNA:
-
Fine needle aspirate
- PBS:
-
Phosphate buffered saline
- PC:
-
Phosphocholine
- GPC:
-
Glycerophosphocholine
- Cho:
-
Choline
- PtC:
-
Phosphatidylcholine
- PL:
-
Phospholipid
- PE:
-
Phosphoethanolamine
- GPE:
-
Glycerophosphoethanolamine
- IDC:
-
Infiltrating ductal carcinoma
- ILC:
-
Infiltrating lobular carcinoma
References
Podo F (1999) Tumour phospholipid metabolism. NMR Biomed 12:413–439
Podo F, Canevari S, Canese R, Pisanu ME, Ricci A, Iorio E (2011) MR evaluation of response to targeted treatment in cancer cells. NMR Biomed 24:648–672
Glunde K, Bhujwalla ZM, Ronen SM (2011) Choline metabolism in malignant transformation. Nat Rev Cancer 11:835–848
Aboagye EO, Bhujwalla ZM (1999) Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells. Cancer Res 59:80–84
Sitter B, Lundgren S, Bathen TF, Halgunset J, Fjosne HE, Gribbestad IS (2006) Comparison of HR MAS MR spectroscopic profiles of breast cancer tissue with clinical parameters. NMR Biomed 19:30–40
Katz-Brull R, Seger D, Rivenson-Segal D, Rushkin E, Degani H (2002) Metabolic markers of breast cancer: enhanced choline metabolism and reduced choline-ether-phospholipid synthesis. Cancer Res 62:1966–1970
Glunde K, Jie C, Bhujwalla ZM (2004) Molecular causes of the aberrant choline phospholipid metabolism in breast cancer. Cancer Res 64:4270–4276
Glunde K, Ackerstaff E, Mori N, Jacobs MA, Bhujwalla ZM (2006) Choline phospholipid metabolism in cancer: consequences for molecular pharmaceutical interventions. Mol Pharmaceutics 3:496–506
Morse DL, Carroll D, Day S, Gray H, Sadarangani P, Murthi S, Job C, Baggert B, Raghunand N, Gillies RJ (2009) Characterization of breast cancers and therapy response by MRS and quantitative gene expression profiling in the choline pathway. NMR Biomed 22:114–127
Podo F, Sardanelli F, Iorio E, Canese R, Carpinelli G, Fausto A, Canevari S (2007) Abnormal choline phospholipid metabolism in breast and ovary cancer: molecular bases for noninvasive imaging approaches. Curr Med Imaging Rev 3:123–137
Eliyahu G, Kreizman T, Degani H (2007) Phosphocholine as a biomarker of breast cancer: molecular and biochemical studies. Int J Cancer 120:1721–1730
Mountford C, Lean C, Malycha P, Russell P (2006) Proton spectroscopy provides accurate pathology on biopsy and in vivo. J Magn Reson Imaging 24:459–477
Haddadin IS, McIntosh A, Meisamy S, Corum C, Styczynski Snyder AL, Powell NJ, Nelson MT, Yee D, Garwood M, Bolan PJ (2009) Metabolite quantification and high-field MRS in breast cancer. NMR Biomed 22:65–76
Sharma U, Jagannathan NR (2009) Biochemical characterization of breast tumors by in vivo and in vitro magnetic resonance spectroscopy (MRS). Biophys Rev 1:21–26
Klomp DWJ, van de Bank BL, Raaijmakers A, Korteweg MA, Possanzini C, Boer VO, van de Berg CAT, van de Bosch MAAJ, Luijten PR (2011) 31P MRSI and 1H MRS at 7 T: initial results in human breast cancer. NMR Biomed 24:1337–1342
Gribbestad IS, Sitter B, Lundgren S, Krane J, Axelson D (1999) Metabolite composition in breast tumors examined by proton nuclear magnetic resonance spectroscopy. Anticancer Res 19:1737–1746
Whitehead TL, Kieber-Emmons T (2005) Applying in vitro NMR spectroscopy and 1H NMR metabonomics to breast cancer characterization and detection. Prog NMR Spectrosc 47:165–174
Kumar M, Seenu V, Julka PK, Srivastava A, Kapila K, Rath GK, Jagannathan NR (2005) Proton MR spectroscopy of human breast cancer. In: Jagannathan NR (ed) Recent advances in mr imaging and spectroscopy. Jaypee Bros, New Delhi, pp 312–344
Sitter B, Bathen TF, Tessem M-B, Gribbestad IS (2009) High-resolution magic angle spinning (HR-MAS) MR spectroscopy in metabolic characterization of human cancer. Prog NMR Spectrosc 54:239–254
Beckonert O, Coen M, Keun HC, Wang Y, Ebbels TMD, Holmes E, Lindon JC, Nicholson JK (2010) High-resolution magic-angle-spinning NMR spectroscopy for metabolic profiling of intact tissues. Nature Prot 5:1019–1032
Sitter B, Bathen TF, Singstad TE, Fjosne HE, Lundgren S, Halgunset J, Gribbestad IS (2010) Quantification of metabolites in breast cancer patients with different clinical prognosis using HR MAS MR spectroscopy. NMR Biomed 23:424–431
Mackinnon WB, Barry PA, Malycha PL, Gillett DJ, Russell P, Lean CL, Doran ST, Barraclough BH, Bilous M, Mountford CE (1997) Fine-needle biopsy specimens of benign breast lesions distinguished from invasive cancer ex vivo with proton MR spectroscopy. Radiology 204:661–666
Mountford CE, Somorjai RL, Malycha P, Gluch L, Lean C, Russell P, Barraclough B, Gillett D, Himmelreich U, Dolenko B, Nikulin AE, Smith ICP (2001) Diagnosis and prognosis of breast cancer by magnetic resonance spectroscopy of fine-needle aspirates analysed using a statistical classification strategy. Br J Surg 88:1234–1240
Lean C, Doran S, Somorjai RL, Malycha P, Clarke D, Himmelreich U, Bourne R, Dolenko R, Nikulin AE, Mountford C (2004) Determination of grade and receptor status from the primary breast lesion by magnetic resonance spectroscopy. Technol Cancer Res Treat 3:551–556
Bourne R, Dzendrowskyj T, Mountford C (2003) Leakage of metabolites from tissue biopsies can result in large errors in quantitation by MRS. NMR Biomed 16:96–101
Komoroski RA, Pearce JM, Mrak RE (2008) 31P NMR spectroscopy of phospholipid metabolites in postmortem schizophrenic brain. Magn Reson Med 59:469–474
Dimitrov IE, Douglas D, Ren J, Smith NB, Webb AG, Sherry AD, Malloy CR (2012) In vivo determination of human breast fat composition by 1H magnetic resonance spectroscopy at 7 T. Magn Reson Med 67:20–26
Smith TAD, Glaholm J, Leach MO, Machin L, Collins DJ, Payne GS, McCready VR (1991) A comparison of in vivo and in vitro 31P NMR spectra from human breast tumours: variations in phospholipid metabolism. Br J Cancer 63:514–516
van Asten JJA, Cuijpers V, Hulsbergen-van de Kaa C, Soede-Huijbregts C, Witjes JA, Verhofstad A, Heerschap A (2008) High resolution magic angle spinning NMR spectroscopy for metabolic assessment of cancer presence and Gleason score in human prostate needle biopsies. Magn Reson Mater Phy 21:435–442
Santos CF, Kurhanewicz J, Tabatabai ZL, Simko JP, Keshari KR, Gbegnon A, Delos Santos R, Federman S, Shinohara K, Carroll PR, Haqq CM, Swanson MG (2010) Metabolic, pathologic, and genetic analysis of prostate tissues: quantitative evaluation of histopathologic and mRNA integrity after HR-MAS spectroscopy. NMR Biomed 23:391–398
Schenetti L, Mucci A, Parenti F, Cagnoli R, Righi V, Tosi MR, Tugnoli V (2006) HR-MAS NMR spectroscopy in the characterization of human tissues: application to healthy gastric mucosa. Concepts Magn Reson 28A:430–443
Moestue SA, Borgan E, Huuse EM, Lindholm EM, Sitter B, Børresen-Dale A-L, Engebraaten O, Mælandsmo GM, Gribbestad IS (2010) Distinct choline metabolic profiles are associated with differences in gene expression for basal-like and luminal-like breast cancer xenograft models. BMC Cancer 10:433–445
Mahoney MC, Lee JH, Chu WJ, Pearce JM, Cecil KM, Strakowski SM, Komoroski RA (2010) Choline metabolite ratios from NMR as markers of human breast cancer. In: Proceedings of the 18th scientific meeting, International Society for Magnetic Resonance in Medicine, Stockholm, p 2765
Acknowledgments
We thank Monene Kamm for assistance.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pearce, J.M., Mahoney, M.C., Lee, JH. et al. 1H NMR analysis of choline metabolites in fine-needle-aspirate biopsies of breast cancer. Magn Reson Mater Phy 26, 337–343 (2013). https://doi.org/10.1007/s10334-012-0349-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10334-012-0349-0